Alternative perspectives in studying acquisitions
نویسندگان
چکیده
منابع مشابه
Studying complementary and alternative therapies.
IN 1992, WITH AN INITIAL BUDGET OF $2 MILLION, Congress created the Office of Alternative Medicine (OAM). Based on legislation sponsored by Iowa politicians Tom Harkin and Berkeley Bedell, OAM’s mission was “to explore complementary and alternative healing practices in the context of rigorous science.” Senator Harkin reportedly believed that bee pollen had cured his hay fever, and Representativ...
متن کاملAlternative splicing: current perspectives.
Alternative splicing is a well-characterized mechanism by which multiple transcripts are generated from a single mRNA precursor. By allowing production of several protein isoforms from one pre-mRNA, alternative splicing contributes to proteomic diversity. But what do we know about the origin of this mechanism? Do the same evolutionary forces apply to alternatively and constitutively splice exon...
متن کاملPerspectives on Firm Decision Making During Risky Technology Acquisitions
A novel survey dataset on computed tomography (CT) machine acquisition is used to explore which theories best answer two questions from the decision making literature. First, what determines how much uncertainty a firm has when investing in updated technology? Second, what determines the value of the acquisition? In answering these questions, two theoretical comparisons are conducted. In the fi...
متن کاملProblems and perspectives in studying the biological role of carnosine.
In describing carnosine among the constituents of muscle tissue in 1900, V. Gulevitsch opened the question of its real biological role. Investigation of carnosine-related phenomena occurred simultaneously with the study of its metabolic transformation within the cell. It has now been demonstrated that carnosine has the ability to protect cells against oxidative stress as well as to increase the...
متن کاملHER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
HER-2 (ErbB-2, c-erbB2 or Her2/neu), a member of the HER-family, is directly involved in the pathogenesis and progression of several human cancers; as such, it is also often considered as a poor prognostic factor. Following the revolutionary impact of anti-HER-2 therapy in breast cancer patients, the role of HER-2 and its blockade has also been extensively evaluated in other tumor types, includ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revizor
سال: 2019
ISSN: 1450-7005,2620-1461
DOI: 10.5937/rev1988021s